Newsroom

Sorted by: Latest

-

Mastercard to Participate in Upcoming Investor Conferences

PURCHASE, N.Y.--(BUSINESS WIRE)--Mastercard (NYSE: MA) today announced its participation in two investor conferences in the month of May....
-

Virtus Total Return Fund Inc. Discloses Sources of Distribution – Section 19(a) Notice

HARTFORD, Conn.--(BUSINESS WIRE)--Virtus Total Return Fund Inc. (NYSE: ZTR) previously announced the following monthly distribution on March 4, 2026: Ticker Amount of Distribution Ex-Date/Record Date Payable Date ZTR $0.05 April 13, 2026 April 29, 2026 Under the terms of its Managed Distribution Plan, the Fund will seek to maintain a consistent distribution level that may be paid, in part or in full, from net investment income and realized capital gains, or a combination thereof. Shareholders s...
-

F5 Adds Anand Eswaran to its Board of Directors

SEATTLE--(BUSINESS WIRE)--F5, Inc. (NASDAQ: FFIV), the global leader in delivering and securing every app and API, today announced the appointment of Anand Eswaran to its board of directors. Eswaran’s executive-level experience at innovative software companies makes him a valuable addition to F5’s board. Mr. Eswaran joined F5’s board effective April 24, 2026 and will serve as a member of the board’s Audit and Talent and Compensation Committees. “Anand brings deep technology leadership to the F5...
-

NOG Announces First Quarter 2026 Results

MINNEAPOLIS--(BUSINESS WIRE)--NOG Announces First Quarter 2026 Results...
-

Ingersoll Rand Reports First Quarter 2026 Results

DAVIDSON, N.C.--(BUSINESS WIRE)--Ingersoll Rand Inc. (NYSE: IR), a global provider of mission-critical flow creation and life science and industrial solutions, reported its results for the first quarter 2026. “We began 2026 with solid momentum, delivering high single-digit Adjusted EPS1 growth and meeting our expectations for revenue and Adjusted EBITDA1,” said Vicente Reynal, chairman and chief executive officer of Ingersoll Rand. “With a robust M&A pipeline, we remain confident in reachin...
-

A10 Networks Reports Financial Results for the First Quarter of 2026

SAN JOSE, Calif.--(BUSINESS WIRE)--A10 Networks, Inc. (NYSE: ATEN), a leading provider of secure application services and solutions, today announced financial results for its first quarter ended March 31, 2026. First Quarter 2026 Financial Summary Quarterly revenue of $75.0 million (up 13.4% year-over-year). GAAP gross margin of 79.6%; non-GAAP gross margin of 80.6%. GAAP net income of $12.0 million, or $0.17 per diluted share, non-GAAP net income of $17.7 million, or $0.24 per diluted share. N...
-

InvenTrust Properties Corp. Reports 2026 First Quarter Results

DOWNERS GROVE, Ill.--(BUSINESS WIRE)--InvenTrust Properties Corp. (“InvenTrust” or the “Company”) (NYSE: IVT) today reported financial and operating results for the quarter ended March 31, 2026. For the three months ended March 31, 2026 and 2025, the Company reported Net Income of $5.2 million, or $0.07 per diluted share, and Net Income of $6.8 million, or $0.09 per diluted share, respectively. First Quarter 2026 Highlights: Nareit FFO of $0.53 per diluted share Core FFO of $0.49 per diluted sh...
-

Werner Enterprises Reports First Quarter 2026 Results

OMAHA, Neb.--(BUSINESS WIRE)--Werner Enterprises, Inc. (Nasdaq: WERN), a premier transportation and logistics provider, today reported results for the first quarter ended March 31, 2026. "The first quarter reflects early results from our strategic positioning and positive momentum in our core business," said Derek Leathers, Chairman and CEO. "Dedicated revenue and fleet size grew, bolstered by our FirstFleet acquisition, improving rates, and a strong 95% customer retention rate. Restructuring i...
-

Sensata Technologies Reports First Quarter 2026 Financial Results

SWINDON, United Kingdom--(BUSINESS WIRE)--Sensata Technologies Reports First Quarter 2026 Financial Results...
-

CareDx Announces Agreement to Acquire Naveris, A Leader in Viral-Mediated Cancer MRD Surveillance Testing

BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced it has entered into a definitive agreement to acquire Naveris, a commercial stage precision oncology diagnostics company with a highly differentiated and Medicare-reimbursed, blood‑based monito...